Spyre Therapeutics, Inc. (SYRE)
Market Closed
17 Jul, 20:00
$
100. 23
+6.11
+6.4917%
$
5.9B Market Cap
- P/E Ratio
- Div Yield
1.09M Volume
- Eps
$ 94.12
Previous Close 
Want to track SYRE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Spyre Therapeutics, Inc. (SYRE) Statistics
Valuation metrics
Market Cap 5.9B
Enterprise value 5.96B
Trailing P/E (ttm) -45.98
Forward P/E -
PEG ratio 0.91
Price/Sales (ttm) 66.9
Price/Book (mrq) 51.7
Enterprise Value/Revenue 65.83
Enterprise Value/EBITDA -29.59
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 943.94K
Average volume (90 days) 1.22M
Price summary
52-Week low 14.51
52-Week high 105.09
Beta -
50-Day moving average 88.38
200-Day moving average 51.64
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 8 Sep 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.98%
Operating margin -2.56%
Operational effectiveness
Return on assets -0.23%
Return on equity -0.31%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.26
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.52
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.14
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 8.97%
Book value per share (mrq) 1.94
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
